We are live on ! Find out more
GSK icon

GSK
GSK

846 hedge funds and large institutions have $10.4B invested in GSK in 2023 Q3 according to their latest regulatory filings, with 99 funds opening new positions, 305 increasing their positions, 268 reducing their positions, and 69 closing their positions.

New
Increased
Maintained
Reduced
Closed

226% more call options, than puts

Call options by funds: $414M | Put options by funds: $127M

43% more first-time investments, than exits

New positions opened: 99 | Existing positions closed: 69

14% more repeat investments, than reductions

Existing positions increased: 305 | Existing positions reduced: 268

9% more funds holding in top 10

Funds holding in top 10: 11 → 12 (+1)

2% more funds holding

Funds holding: 827 → 846 (+19)

5% more capital invested

Capital invested by funds: $9.91B → $10.4B (+$453M)

0.19% more ownership

Funds ownership: 6.79% → 6.98% (+0.19%)

Holders
846
Holders Change
+19
Holders Change %
+2.3%
% of All Funds
13.43%
Holding in Top 10
12
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+9.09%
% of All Funds
0.19%
New
99
Increased
305
Reduced
268
Closed
69
Calls
$414M
Puts
$127M
Net Calls
+$287M
Net Calls Change
+$213M

Top Buyers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
+$157M
2
Holocene Advisors
Holocene Advisors
New York
+$74.4M
3
Millennium Management
Millennium Management
New York
+$53.6M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$45.8M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$44.2M

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$127M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$102M
3
JEST
JTC Employer Solutions Trustee
Jersey
-$45.7M
4
Nomura Holdings
Nomura Holdings
Japan
-$45.4M
5
CCM
Camber Capital Management
Massachusetts
-$44.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
PIAS
901
PCA Investment Advisory Services
Ohio
– -$8.06K -226 Closed
HS
902
Horan Securities
United States
– -$7.13K -200 Closed
FA
903
Fiduciary Alliance
South Carolina
– -$6.27K -176 Closed
BG
904
Bollard Group
Massachusetts
– -$5K -153 Closed
BEI
905
Benjamin Edwards Inc
Missouri
– -$4K -114 Closed
LIA
906
Luken Investment Analytics
Tennessee
– -$3.6K -101 Closed
CM
907
Caption Management
Oklahoma
– -$3.55K -100 Closed
FSWA
908
Financial Synergies Wealth Advisors
Texas
– -$3.56K -100 Closed
IPW
909
Impact Partnership Wealth
Georgia
– -$3.56K -100 Closed
BAAM
910
Baker Avenue Asset Management
California
– -$2.63K -74 Closed
2L
911
25 LLC
Missouri
– -$1.6K -46 Closed
TFP
912
Tilia Fiduciary Partners
North Carolina
– -$1.28K -36 Closed
CAS
913
Coppell Advisory Solutions
Texas
– -$955 -27 Closed
TAIM
914
TD Ameritrade Investment Management
Nebraska
– -$1K -17 Closed
TCCM
915
Timber Creek Capital Management
Massachusetts
– -$514 -14 Closed
YDMI
916
Y.D. More Investments
Israel
– -$249 -7 Closed
33 34 35 36
37

GSK Hedge Fund Activity: Q3 2023 in Review

846 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in GSK (GSK) for Q3 2023, worth a combined $10.4B — up 4.6% from $9.91B a quarter earlier.

Buyers outnumbered sellers: 99 funds opened new GSK positions and 69 closed out — a net gain of 30 holders — while 305 added to existing stakes and 268 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $157M. The largest seller was Goldman Sachs, cutting an estimated $127M.

  • 846 institutional investors held GSK (GSK) as of Q3 2023, up from 827 in Q2 2023.
  • Funds reported $10.4B of GSK stock for Q3 2023, up 4.6% quarter-over-quarter.
  • 99 funds opened new GSK positions in Q3 2023 and 69 closed out, a net change of +30 holders.
  • The largest GSK buyer in Q3 2023 was Deutsche Bank, an estimated $157M added.
  • The largest GSK seller in Q3 2023 was Goldman Sachs, an estimated $127M sold.

Based on aggregated 13F filings for Q3 2023.